Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Oncoimmunology|September 28, 2013
Peptide-based anticancer vaccines: The making and unmaking of a T-cell graveyardYared Hailemichael, Willem W OverwijkThe International Journal of Biochemistry & Cell Biology|May 7, 2014
Cancer vaccines: Trafficking of tumor-specific T cells to tumor after therapeutic vaccinationYared Hailemichael, Willem W OverwijkTrends in Molecular Medicine|May 8, 2018
Vaccinating with Stem Cells to Stop CancerYared Hailemichael, Manisha Singh, Willem OverwijkImmunotherapy|February 21, 2012
Conference scene: immune effector mechanisms in tumor immunityAndrew G Sikora, Yared Hailemichael, Willem W OverwijkCurrent Protocols in Immunology|February 3, 2015
Mouse model for pre-clinical study of human cancer immunotherapyZhiya Ya, Yared Hailemichael, Willem Overwijk, et al.Journal of Visualized Experiments : Jove|December 30, 2017
In Vivo Assay for Detection of Antigen-specific T-cell Cytolytic Function Using a Vaccination ModelCara L Haymaker, Yared Hailemichael, Yi Yang, et al.Plos One|March 11, 2015
Soluble interleukin-15 complexes are generated in vivo by type I interferon dependent and independent pathwaysScott M Anthony, Megan E Howard, Yared Hailemichael, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 11, 2011
Antitumor activity mediated by CpG: the route of administration is criticalYanyan Lou, Chengwen Liu, Gregory Lizée, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapyAndrew G Sikora, Alexander Gelbard, Michael A Davies, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2009
IFN-alpha enhances peptide vaccine-induced CD8+ T cell numbers, effector function, and antitumor activityAndrew G Sikora, Nina Jaffarzad, Yared Hailemichael, et al.Pageof 3